flash-tech

Apple acquires materials science company PlasmaSolve

AstraZeneca Plc investors had a clear message for the UK drugmaker on Monday: they don’t like the idea of a $400 billion merger with Bristol-Myers Squibb Co. Bloomberg Intelligence's Director of Research, Sam Fazeli joins to discuss. (Source: Bloomberg)

US stocks rose into the first trading day of the month as attention turned to this week’s heavy slate of earnings reports.

Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets

The wake-up call to the cyber industry comes as industry experts descend on Black Hat, a major cybersecurity conference.

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

CXMT Corp. is one of the most polarizing stocks in Asia, with the range of analyst opinions delineating the key arguments driving volatility in the memory-chip stock trade.

AI funding spree shows signs of strain: higher borrowing costs, SpaceX sell-off

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

U.S. stocks were mostly lower, with the Nasdaq leading declines as makers of AI infrastructure suffered steep falls, many in the double digits. Nvidia was down 16%.